Axcella Health Inc. (AXLA)
Dec 29, 2023 - AXLA was delisted (reason: company dissolved)
0.401
0.00 (0.00%)
Inactive · Last trade price
on Dec 29, 2023
Axcella Health Analyst Ratings
Total Analysts
1
Consensus Rating
Hold
Price Target
n/a
Upside
n/a
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Feb 16, 2023 |
SVB Leerink | SVB Leerink | Buy → Hold Downgrades $150 → $50 | Buy → Hold | Downgrades | $150 → $50 | +12,371.94% | Dec 16, 2022 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 15, 2022 |
Chardan Capital | Chardan Capital | Strong Buy Maintains $175 → $125 | Strong Buy | Maintains | $175 → $125 | +31,079.85% | Nov 2, 2022 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $200 → $250 | Strong Buy | Maintains | $200 → $250 | +62,259.69% | Oct 3, 2022 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $350 → $200 | Strong Buy | Maintains | $350 → $200 | +49,787.75% | Aug 3, 2022 |
SVB Leerink | SVB Leerink | Buy Maintains $225 → $150 | Buy | Maintains | $225 → $150 | +37,315.81% | Aug 3, 2022 |
Chardan Capital | Chardan Capital | Strong Buy Maintains $300 → $175 | Strong Buy | Maintains | $300 → $175 | +43,551.78% | May 9, 2022 |
SVB Leerink | SVB Leerink | Buy Maintains $250 → $225 | Buy | Maintains | $250 → $225 | +56,023.72% | Mar 31, 2022 |
Chardan Capital | Chardan Capital | Strong Buy Maintains n/a | Strong Buy | Maintains | n/a | n/a | Nov 16, 2021 |
Noble Capital Markets | Noble Capital Markets | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Oct 12, 2021 |
Goldman Sachs | Goldman Sachs | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Sep 22, 2021 |
JP Morgan | JP Morgan | Hold → Sell Downgrades n/a | Hold → Sell | Downgrades | n/a | n/a | Jul 30, 2021 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Jul 6, 2021 |
Chardan Capital | Chardan Capital | Strong Buy Maintains n/a | Strong Buy | Maintains | n/a | n/a | Jun 3, 2021 |
Chardan Capital | Chardan Capital | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Oct 27, 2020 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.